Aberrant expression of HDAC7 has been observed in gastric, breast, and ovarian cancer, along with glioma and hematological malignancies [12–16], where high expression of HDAC7 has been correlated with metastasis and poor prognosis [12, 16]. This evidence concerns the gene HDAC7 and central nervous system cancer.